交易中 09-17 11:45:25 美东时间
-0.095
-0.88%
今日重点评级关注:Ascendiant Capital:维持Outlook Therapeutics"买入"评级,目标价从10美元升至10.5美元;摩根士丹利:维持Aurora Innovation"超配"评级,目标价从14美元升至18美元
09-14 16:05
Keybanc analyst Salvator Tiano initiates coverage on FMC (NYSE:FMC) with a Overweight rating and announces Price Target of $16.
09-11 17:43
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. Benzinga readers can review the latest analyst takes on their favorite stocks by v...
08-28 19:47
今日重点评级关注:HC Wainwright & Co.:维持Enlivex"买入"评级,目标价从20美元升至80美元;Canaccord Genuity:维持Pharming Group NV Sponsored ADR"买入"评级,目标价从37美元升至38美元
08-04 11:45
今日重点评级关注:TD Cowen:维持加拿大鹅"买入"评级,目标价从13美元升至18美元;瑞银:维持吉登运动服"买入"评级,目标价从110美元升至111美元
08-03 11:38
Morgan Stanley analyst Vincent Andrews maintains FMC (NYSE:FMC) with a Equal-Weight and lowers the price target from $15.5 to $12.
08-01 01:32
华盛资讯7月30日讯,FMC公司公布2026财年Q2业绩,公司Q2营收8.67亿美元,同比下降17.5%,归母净利润亏损1.87亿美元,由盈转亏。
07-30 05:08
FMC (NYSE:FMC) is looking for Q4 Adj EPS of $1.09-$1.33 vs $1.01 analyst estimate. sees sales of $1.060 billion-$1.200 billion vs $1.095 billion analyst estimate.
07-30 04:33
FMC (NYSE:FMC) lowers FY2026 Adj EPS guidance from $1.63-$1.89 to $1.19-$1.49 vs $1.69 analyst estimate. Lowers FY2026 sales outlook from $3.600 billion-$3.800 billion to $3.500 billion-$3.700 billion vs $3.703 billion estimate.
07-30 04:32
今日重点评级关注:BTIG:上调Outlook Therapeutics"买入"评级,目标价4美元;TD Cowen:维持Nakamoto"买入"评级,目标价从1美元升至17美元
07-28 11:34